American journal of clinical dermatology
Outcomes and Predictors of Sustained Response After Dose Tapering of Targeted Therapies in Moderate-to-Severe Atopic Dermatitis: A Systematic Review
By Mordehachvili Burlá M, de Oliveira Rosa L, Mendes BX and 4 others.
Abstract
Background
Moderate-to-severe atopic dermatitis (AD) often requires prolonged systemic therapy. As disease control is achieved, optimizing dose tapering and identifying factors associated with sustained response are increasingly relevant.